XML 67 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
COMMITMENTS AND CONTINGENCIES (Details) (USD $)
In Thousands, unless otherwise specified
 6 Months Ended 6 Months Ended 1 Months Ended 6 Months Ended
Jun. 30, 2013
Dec. 31, 2012
Jun. 30, 2012
Jun. 30, 2013
Israel [Member]
Jun. 30, 2013
United States [Member]
Jun. 30, 2012
Long-term Prepaid Expenses [Member]
Dec. 31, 2010
Prepaid Expenses and Other Current Assets [Member]
Jun. 30, 2012
Prepaid Expenses and Other Current Assets [Member]
Jun. 30, 2013
Maximum [Member]
Jun. 30, 2013
Minimum [Member]
Bank guarantee in favor of lessor for offices       $ 99 $ 40          
Aggregate contingent obligation for payments to Office of the Chief Scientist 8,762                  
Accrued royalties 6                  
Percentage of sales committed to pay royalties                 3.00% 5.00%
Maximum percentage of total income received from product sales that Compugen will owe royalty fees 100.00%                  
Payment for access right to the Technology     600     400 100 150    
Number of years company has access right to Technology     3 years              
Additional (maximum cumulative) cash consideration to be paid for right of use of Antibody Technology upon occurance of certain development and commercialization milestones     3,250              
Technology access expense $ 158 $ 109